Your browser doesn't support javascript.
loading
T-cell therapy using a bank of EBV-specific cytotoxic T cells: lessons from a phase I/II feasibility and safety study.
Gallot, Géraldine; Vollant, Solène; Saïagh, Soraya; Clémenceau, Béatrice; Vivien, Régine; Cerato, Evelyne; Bignon, Jean-D; Ferrand, Christophe; Jaccard, Arnaud; Vigouroux, Stéphane; Choquet, Sylvain; Dalle, Jean-Hugues; Frachon, Irène; Bruno, Bénédicte; Mothy, Mohamad; Mechinaud, Françoise; Leblond, Véronique; Milpied, Noël; Vié, Henri.
Affiliation
  • Gallot G; *Inserm, U892 †CHU Nantes, Hôtel Dieu, UTCG ‡Etablissement Français du Sang (EFS), Pays de la Loire, Nantes §UMR 1098, EFS Bourgogne/Franche-Comté, Bourgogne/Franche-Comté ∥CHU Limoges, Limoges ¶CHU Bordeaux and University Bordeaux 2, Bordeaux #APHP Hôpital Pitié-Salpêtrière CHU Pitié Salpétrière **CHU Robert Debré §§Hôpital Saint-Antoine, Paris ††CHU Brest, Brest ‡‡CHU Lilles, Lille, France.
J Immunother ; 37(3): 170-9, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24598452

Full text: 1 Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Immunotherapy, Adoptive / Herpesvirus 4, Human / Epstein-Barr Virus Infections / Lymphoma Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article

Full text: 1 Database: MEDLINE Main subject: T-Lymphocytes, Cytotoxic / Immunotherapy, Adoptive / Herpesvirus 4, Human / Epstein-Barr Virus Infections / Lymphoma Type of study: Clinical_trials Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article